Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
โ Scribed by E. Lindholm; H. Brevinge; E. Haglind
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 121 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
positive tests will have colorectal neoplasia, including 5-10 per cent with cancer". Improvements in specificity using vegetable peroxidase inhibitors, faecal porphyrin assays, or immunochemical tests for blood should be possible. None of these tests will discriminate between bleeding from neoplasti
## Abstract Haemoccultยฎ, a guaiac test for faecal occult blood, detects 56โ78 per cent of asymptomatic carcinomas when performed over 3 days. In patients with known colorectal cancer the sensitivity of the test for neoplasia is increased by extending the test period to 6 days. We report the first r